Arbutus Biopharma Corp insider trading

ABUSNASDAQ

$4.45-0.11 (-2.41% today)

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-0.9%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25

Unlock quarterly net flow

Key players

MGMatthew GlineDirector19.635%of company
MJMichael J. McElhaughInterim President & CEO0.838%of company
DCDavid C. HastingsChief Financial Officer0.1263%of company
TNTuan NguyenChief Financial Officer0.0809%of company
KSKaren SimsChief Medical Officer0.0786%of company
NJNaftzger J. ChristopherGeneral Counsel and CCO0.071%of company
LALindsay AndroskiPresident and CEO0.0366%of company
RARobert A. BeardsleyDirector0.0163%of company
RSRoger SawhneyDirector0.0156%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
No qualifying insider activity was found for the selected filters.

End of history · 0 transactions